Clinical trial
Melanoma Accuracy Study, Phase Two
NCT03464604 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Melanoma Accuracy Study, Phase Two
- Lead sponsor
- Nova Scotia Health Authority
- Phase
- Observational
- Overall status
- Terminated
- Start date
- February 28, 2018
- Completion date
- October 10, 2018
- Enrollment
- 121 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.